Cargando…
Higher risk of future events, mortality and greater healthcare use among patients with increasingly recurrent atherosclerotic cardiovascular disease events in Taiwan: a retrospective cohort study
OBJECTIVES: To describe the occurrence of recurrent atherosclerotic cardiovascular disease (ASCVD) events within 3 years after a new-onset event, the associated disease burden and statin prescribing in patients with ASCVD in Taiwan. DESIGN: Retrospective cohort study. SETTING: This was a retrospecti...
Autores principales: | Hsu, Chia-Yun, Chen, Wen-Jone, Lin, Hung-Ju, Chen, Ho-Min, Yang, Yea-Harn, Chen, Wei-Ju, Chen, Chieh-Min, Hsiao, Fei-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357687/ https://www.ncbi.nlm.nih.gov/pubmed/37474164 http://dx.doi.org/10.1136/bmjopen-2022-064219 |
Ejemplares similares
-
Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
por: Inno, Alessandro, et al.
Publicado: (2021) -
Comparing Characteristics of Adverse Drug Events Between Older and Younger Adults Presenting to a Taiwan Emergency Department
por: Chen, Yen-Chia, et al.
Publicado: (2015) -
Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study
por: Ho, Wen-Yu, et al.
Publicado: (2022) -
Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
por: Zhao, Li-Min, et al.
Publicado: (2021) -
The relationship between Type D personality with atherosclerotic plaque and cardiovascular events: The mediation effect of inflammation and kynurenine/tryptophan metabolism
por: Wang, Yini, et al.
Publicado: (2022)